CD146 bound to LCK promotes T cell receptor signaling and antitumor immune responses in mice
Hongxia Duan,Lin Jing,Xiaoqing Jiang,Yanbin Ma,Daji Wang,Jianquan Xiang,Xuehui Chen,Zhenzhen Wu,Huiwen Yan,Junying Jia,Zheng Liu,Jing Feng,Mingzhao Zhu,Xiyun Yan
DOI: https://doi.org/10.1172/JCI148568
2021-11-01
Abstract:Initiation of T cell receptor (TCR) signaling involves the activation of the tyrosine kinase LCK; however, it is currently unclear how LCK is recruited and activated. Here, we have identified the membrane protein CD146 as an essential member of the TCR network for LCK activation. CD146 deficiency in T cells substantially impaired thymocyte development and peripheral activation, both of which depend on TCR signaling. CD146 was found to directly interact with the SH3 domain of coreceptor-free LCK via its cytoplasmic domain. Interestingly, we found CD146 to be present in both monomeric and dimeric forms in T cells, with the dimerized form increasing after TCR ligation. Increased dimerized CD146 recruited LCK and promoted LCK autophosphorylation. In tumor models, CD146 deficiency dramatically impaired the antitumor response of T cells. Together, our data reveal an LCK activation mechanism for TCR initiation. We also underscore a rational intervention based on CD146 for tumor immunotherapy.
What problem does this paper attempt to address?